CAD and Global developmental delay: CAD (p. Arg 2024 Gln) mutation with loss function of carbamoyl–phosphate binding, causes developmental delays and epileptic encephalopathy, which implicates that CAD deficiency is linked tightly with neurometabolic disorders.